AI Reshapes Industries: TraqCheck Secures $8M, Healync Gains PE Boost
April 18, 2026, 3:41 pm
AI innovation is reshaping industries. Tech firms are securing substantial capital. TraqCheck, a London-headquartered HR tech startup, recently raised $8 million in Series A funding. IvyCap Ventures led this significant round, with IIFL participation. The company pioneers autonomous AI agents for end-to-end recruitment. Trace handles background screening. Nina manages real-time conversational sourcing. TraqCheck aims to deepen its market presence across India and Europe, serving SMBs and large enterprises. Meanwhile, Healync Technologies, another innovative firm, secured undisclosed private equity investment from Volrado Venture. Healync focuses on transforming healthcare delivery. Its initiatives include Healync Private Health, offering personalized medical task forces for complex cases, and Aayu, a SaaS platform digitizing hospital operations. This investment fuels Healync's global expansion, strengthening its specialist network and technology infrastructure. Both funding rounds highlight strong investor confidence in AI-driven solutions and advanced healthcare technology. They propel significant digital transformation across critical sectors.
Venture capital flows into disruptive technology. Artificial intelligence drives this new wave. Two companies, TraqCheck and Healync, exemplify this trend. They secured significant investment. Their strategies target key sectors: human resources and healthcare.
TraqCheck leads the charge in AI-native HR solutions. The startup raised $8 million. This was a Series A funding round. IvyCap Ventures spearheaded the investment. IIFL also participated. This capital infusion powers TraqCheck's ambitious expansion plans.
The company's core mission centers on autonomous AI agents. These agents re-engineer recruitment workflows. They aim to replace traditional software. TraqCheck envisions a "Human Operating System." This system executes entire recruitment processes. It spans candidate sourcing to background checks.
Key products include Trace and Nina. Trace specializes in background screening. It offers automated verification for enterprises. Nina functions as a real-time conversational sourcing agent. This dual approach streamlines hiring. It boosts efficiency significantly.
Founders Armaan Mehta and Jaibir Nihal Singh established TraqCheck. The firm began in New Delhi. It now operates from London. An office remains in India. This dual presence supports broad market reach.
Funding targets key growth areas. TraqCheck plans to expand Trace's adoption. Small and medium-sized businesses will benefit. Large enterprise customers are also a focus. The company aims for deeper market penetration across India and Europe. Scaling go-to-market efforts for Nina is another priority.
TraqCheck boasts an impressive client base. Nearly 300 enterprise customers utilize its services. These clients span India and Europe. Their solutions are gaining traction. Early backing came from notable individual investors. Peyush Bansal and Alok Oberoi previously supported the company.
The investment reflects a significant industry shift. Legacy HR software is giving way to AI-native systems. Recruiters seek autonomous agents. These agents execute tasks independently. They move beyond mere information display. TraqCheck is building systems that collaborate and make decisions. This marks a profound evolution in HR technology.
Industry experts recognize TraqCheck's platform. They see it as DeepTech AI-native innovation. It re-imagines talent acquisition. It also transforms verification processes. The team demonstrates strong product vision. Execution addresses real enterprise challenges. HR may become an early adopter of full automation. This outlook drives investor interest. Enterprises are experimenting with AI across departments. The future hiring team will feature more digital colleagues, fewer dashboards.
On a different front, Healync Technologies secured private equity. Volrado Venture made this strategic investment. The undisclosed amount supports two critical healthcare verticals. Healync aims to transform medical care.
Its first vertical is Healync Private Health. This offers a personalized medical task force. It addresses complex medical cases. Chronic disorders, cancer care, and transplant coordination are included. Neurological rehabilitation and advanced surgical planning also feature. The service integrates preventive health strategies. Longevity-focused care is a core component.
The second vertical is Aayu. Aayu is a software-as-a-service (SaaS) platform. It digitizes hospital operations. It streamlines various healthcare processes. This enhances efficiency within medical institutions.
Founders Rashi Saraogi and Yagyaansh Goenka steer Healync. Their vision focuses on comprehensive health solutions. The investment fuels significant expansion. It will bolster Healync’s global specialist network. Technology infrastructure will see upgrades. Institutional partnerships will grow stronger.
Healync supports a broad spectrum of medical needs. From complex chronic conditions to proactive prevention, its services are comprehensive. This holistic approach sets it apart. The company’s focus on personalized care resonates in today's healthcare landscape. Digital solutions are becoming indispensable for better patient outcomes. They also optimize hospital management.
Both TraqCheck and Healync represent critical innovation. They attract substantial capital. This underscores investor confidence in their sectors. AI and advanced healthcare technology are driving future economies. These firms are at the forefront. They are not just enhancing existing systems. They are building entirely new paradigms. Their efforts promise significant industry-wide transformation. Digital evolution continues to accelerate across global markets.
Venture capital flows into disruptive technology. Artificial intelligence drives this new wave. Two companies, TraqCheck and Healync, exemplify this trend. They secured significant investment. Their strategies target key sectors: human resources and healthcare.
TraqCheck leads the charge in AI-native HR solutions. The startup raised $8 million. This was a Series A funding round. IvyCap Ventures spearheaded the investment. IIFL also participated. This capital infusion powers TraqCheck's ambitious expansion plans.
The company's core mission centers on autonomous AI agents. These agents re-engineer recruitment workflows. They aim to replace traditional software. TraqCheck envisions a "Human Operating System." This system executes entire recruitment processes. It spans candidate sourcing to background checks.
Key products include Trace and Nina. Trace specializes in background screening. It offers automated verification for enterprises. Nina functions as a real-time conversational sourcing agent. This dual approach streamlines hiring. It boosts efficiency significantly.
Founders Armaan Mehta and Jaibir Nihal Singh established TraqCheck. The firm began in New Delhi. It now operates from London. An office remains in India. This dual presence supports broad market reach.
Funding targets key growth areas. TraqCheck plans to expand Trace's adoption. Small and medium-sized businesses will benefit. Large enterprise customers are also a focus. The company aims for deeper market penetration across India and Europe. Scaling go-to-market efforts for Nina is another priority.
TraqCheck boasts an impressive client base. Nearly 300 enterprise customers utilize its services. These clients span India and Europe. Their solutions are gaining traction. Early backing came from notable individual investors. Peyush Bansal and Alok Oberoi previously supported the company.
The investment reflects a significant industry shift. Legacy HR software is giving way to AI-native systems. Recruiters seek autonomous agents. These agents execute tasks independently. They move beyond mere information display. TraqCheck is building systems that collaborate and make decisions. This marks a profound evolution in HR technology.
Industry experts recognize TraqCheck's platform. They see it as DeepTech AI-native innovation. It re-imagines talent acquisition. It also transforms verification processes. The team demonstrates strong product vision. Execution addresses real enterprise challenges. HR may become an early adopter of full automation. This outlook drives investor interest. Enterprises are experimenting with AI across departments. The future hiring team will feature more digital colleagues, fewer dashboards.
On a different front, Healync Technologies secured private equity. Volrado Venture made this strategic investment. The undisclosed amount supports two critical healthcare verticals. Healync aims to transform medical care.
Its first vertical is Healync Private Health. This offers a personalized medical task force. It addresses complex medical cases. Chronic disorders, cancer care, and transplant coordination are included. Neurological rehabilitation and advanced surgical planning also feature. The service integrates preventive health strategies. Longevity-focused care is a core component.
The second vertical is Aayu. Aayu is a software-as-a-service (SaaS) platform. It digitizes hospital operations. It streamlines various healthcare processes. This enhances efficiency within medical institutions.
Founders Rashi Saraogi and Yagyaansh Goenka steer Healync. Their vision focuses on comprehensive health solutions. The investment fuels significant expansion. It will bolster Healync’s global specialist network. Technology infrastructure will see upgrades. Institutional partnerships will grow stronger.
Healync supports a broad spectrum of medical needs. From complex chronic conditions to proactive prevention, its services are comprehensive. This holistic approach sets it apart. The company’s focus on personalized care resonates in today's healthcare landscape. Digital solutions are becoming indispensable for better patient outcomes. They also optimize hospital management.
Both TraqCheck and Healync represent critical innovation. They attract substantial capital. This underscores investor confidence in their sectors. AI and advanced healthcare technology are driving future economies. These firms are at the forefront. They are not just enhancing existing systems. They are building entirely new paradigms. Their efforts promise significant industry-wide transformation. Digital evolution continues to accelerate across global markets.